Clinical trial
Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer
To determine the clinical activity of SUTENT® (sunitinib malate) in non-clear cell renal cell cancer (RCC). Clinical activity will take into account response rate and progression free survival (PFS).
| Category | Value |
|---|---|
| Study start date | 2007-04-20 |